Magnesium for treating sickle cell disease.

CONCLUSIONS: Moderate to low quality evidence showed neither intravenous magnesium and oral magnesium therapy has an effect on reducing painful crisis, length of hospital stay and changing quality of life in treating sickle cell disease. Therefore, no definitive conclusions can be made regarding its clinical benefit. Further randomized controlled studies, perhaps multicentre, are necessary to establish whether intravenous and oral magnesium therapies have any effect on improving the health of people with sickle cell disease.
PMID: 31498421 [PubMed - as supplied by publisher]

Source: Cochrane Database of Systematic Reviews - September 8, 2019 Category: General Medicine Authors: Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L Tags: Cochrane Database Syst Rev Source Type: research